Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Histological classification of chronic hepatitis

¹K.U.Leuven, Department of Pathology, Belgium.

Acta Gastro-Enterologica Belgica

|April 8, 1998

Summary

The 1968 chronic hepatitis classification is outdated due to newly discovered causes like viruses and drugs. A 1994 proposal emphasizes etiology, grading, and staging for better treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comments on cirrhosis reversal.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2005

Same author

Histopathology of chronic cholestasis and adult ductopenic syndrome.

Clinics in liver disease·2004

Same author

Reversal of cirrhosis: evidence-based medicine?

Gastroenterology·2003

Same author

Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors.

Hepatology (Baltimore, Md.)·2000

Same author

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Journal of hepatology·1999

Same author

Expression of cytokeratin 20 in developing rat liver and in experimental models of ductular and oval cell proliferation.

Journal of hepatology·1998

Area of Science:

Hepatology
Gastroenterology
Virology

Background:

The 1968 chronic hepatitis classification distinguished stages and activity (persistent vs. aggressive), suitable when etiology was unknown and presumed autoimmune.
Immunosuppressive therapy was reserved for severe cases, validating the classification's utility at the time.

Purpose of the Study:

To address the need for an updated chronic hepatitis classification following the discovery of diverse etiologies (hepatitis viruses B, D, C, G, drug toxicity, autoimmune hepatitis).
To introduce the 1994 proposals from the International Association for the Study of the Liver and World Congresses of Gastroenterology for a new classification system.

Main Methods:

The proposed classification emphasizes primary categorization by etiology.
It incorporates determination of disease severity (grading) and stage of progression (staging).
Availability of semiquantitative scoring systems for histological grading and staging of liver biopsies is noted.

Main Results:

The 1994 proposals aimed to align classification with the need for divergent therapeutic approaches based on etiology.
Semiquantitative scoring systems are valuable for evaluating new treatment regimens and comparing pre- and post-treatment biopsies.
Routine reporting of liver biopsies does not require semiquantitative scoring.

Conclusions:

The evolution of chronic hepatitis understanding necessitates a classification system that accounts for diverse etiologies.
Etiology-based classification, coupled with grading and staging, is crucial for guiding appropriate therapeutic strategies.
While semiquantitative scoring aids research and treatment evaluation, it is not standard for routine biopsy reporting.

Related Experiment Videos